Alx Oncology Holdings (ALXO) Return on Sales [ROS] (2019 - 2022)
Alx Oncology Holdings' Return on Sales [ROS] came in at -9986.53% for Q1 2021, down 9186.22 percentage points from -800.31% a year earlier and down 6292.53 percentage points from the prior quarter.
Powered by 
Analysis
Alx Oncology Holdings (ALXO) Return on Sales [ROS] (2019 - 2022) Analysis & Trends
For FY2020, Alx Oncology Holdings' Return on Sales [ROS] was -3693.99%, down 3294.01 percentage points from FY2019.
- Going back by year, Return on Sales [ROS] was -399.98% in FY2019 (+262.04 pp) and -662.02% in FY2018.
- The Q1 2021 figure represents the lowest quarterly Return on Sales [ROS] in data going back to Q2 2019.
- Year-over-year, Return on Sales [ROS] has declined for four consecutive quarters, with an average year-over-year change of -3781.56 percentage points over the last four quarters.
- Business Quant data shows ALXO's Return on Sales [ROS] at -3693.99% (Q4 2020), -1401.71% (Q3 2020) and -2046.87% (Q2 2020) in the three quarters before Q1 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 29.12% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 32.98% |
| 10 | Alx Oncology Holdings | 153.42 Mn | -230.55 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | -1,783.01% |
| Sep 30, 2022 | -2,677.45% |
| Jun 30, 2022 | -3,857.19% |
| Mar 31, 2022 | -10,998.67% |
| Dec 31, 2021 | -135,580.95% |
| Sep 30, 2021 | -111,709.09% |
| Jun 30, 2021 | -70,865.22% |
| Mar 31, 2021 | -9,986.53% |
| Dec 31, 2020 | -3,693.99% |
| Sep 30, 2020 | -1,401.71% |
| Jun 30, 2020 | -2,046.87% |
| Mar 31, 2020 | -800.31% |
| Dec 31, 2019 | -637.51% |
| Sep 30, 2019 | -241.56% |
| Jun 30, 2019 | -323.47% |
API Access
Alx Oncology Holdings Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ALXO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "ALXO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ALXO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();